Author

K. AboulFotouh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4

Frequent Co-Authors

R. O. Williams· 4 shared Z. Cui· 4 shared C. Cano· 3 shared H. Xu· 3 shared G. Williams· 2 shared J. Suman· 2 shared S. Sahakijpijarn· 2 shared Y.-S. Yu· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersPharmacology & Toxicology

R. O. Williams

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Feasibility of intranasal delivery of thin-film freeze-dried monoclonal antibodies

Y.-S. Yu, H. Xu, K. AboulFotouh, G. Williams, J. Suman, S. Sahakijpijarn, C. Cano, Z. Warnken, K. C.- W. Wu, R. O. Williams, Z. Cui

This paper demonstrates the feasibility of intranasally delivering monoclonal antibodies as dry powders using thin-film freeze-drying and the UDS Powder Nasal Spray System.

bioRxiv · Oct 23, 2023 · PreprintPharmacology & Toxicology

Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive AS01B-adjuvanted vaccine powders

Y.-S. Yu, K. AboulFotouh, G. Williams, J. Suman, C. Cano, Z. N. Warnken, R. O. Williams, Z. Cui

This study demonstrates that thin-film freeze-drying can convert a liquid vaccine into a dry powder with mucoadhesive properties, which can be effectively delivered using a nasal device for intranasal vaccination.

bioRxiv · Nov 1, 2022 · PreprintPharmacology & Toxicology

Development of Dry Powder Formulations of AS01B containing vaccines using Thin-Film Freeze-Drying

K. AboulFotouh, H. Xu, R. O. Williams, Z. Cui

This study demonstrates that thin-film freeze-drying can produce freezing-insensitive dry powders of AS01B-adjuvanted vaccines without compromising liposome integrity or immunogenicity.

bioRxiv · Feb 27, 2022 · PreprintPharmacology & Toxicology

Formulation of Dry Powders of Vaccines Containing MF59 or AddaVax by Thin-Film Freeze-Drying

K. AboulFotouh, N. Uno, H. Xu, C. Moon, S. Sahakijpijarn, D. J. Christensen, G. J. Davenport, C. Cano, T. M. Ross, R. O. Williams, Z. Cui

This study demonstrates that thin-film freeze-drying can convert MF59 or AddaVax-adjuvanted vaccines into dry powders while preserving immunogenicity and stability.

bioRxiv · Oct 21, 2021 · PreprintPharmacology & Toxicology